Topics

Batu Biologics Inc. Company Profile

14:48 EDT 19th September 2019 | BioPortfolio


News Articles [545 Associated News Articles listed on BioPortfolio]

Management tracks: Batu, Halozyme, FOG

DSM Biologics: Karen King on New Technology and Reducing the Cost of Medicines

In this episode of PharmaTelevision News Review, Fintan Walton talks with Karen King, President and Business Unit Director of DSM Biologics. Filmed at BioChicago 2010 in Chicago, USA, they discuss: ...

Evotec AG: Evotec Jump-Starts Biologics with Acquisition of Just Biotherapeutics

EVOTEC'S OFFERING OF INTEGRATED SOLUTIONS EXTENDED TO BIOLOGICS ADDITION OF LONGSTANDING BIOLOGICS EXPERTISE BASED ON KEY TALENTS, INNOVATIVE ML (MACHINE LEARNING) DRIVEN TECHNOLOGIES AND SOPHISTIC...

Heat Biologics, Inc.: Heat Biologics CEO to Present at the ThinkEquity Conference in New York City

DURHAM, NC / ACCESSWIRE / April 18, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies designed to activate a patient's immune system against cancer,...

Heat Biologics, Inc.: Heat Biologics to Present at the 20th Annual B. Riley FBR Institutional Investor Conference

DURHAM, NC / ACCESSWIRE / May 20, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing therapies designed to activate a patient's immune system against cancer, today a...

WuXi Biologics adds ADC commercial manufacturing at WuXi city facility

WuXi Biologics expands its biologics conjugation solution center to include space for commercial manufacturing of antibody-drug conjugates for the biopharma industry.

WuXi Biologics Starts Building Chengdu Manufacturing Plant, its 12th Globally

WuXi Biologics, a China biologics CRO/CMO, has begun construction of a new 1.3 million square foot integrated manufacturing center for innovative biologics in Chengdu, one of the largest cities in Sou...

EMA hat Pre-Approval Inspection der cGMP-DS- und DP-Fertigungsstätten für Trogarzo von WuXi Biologics abgeschlossen

WuXi Biologics, das erste Biologika-Unternehmen in China, hat die EMA GMP Inspection abgeschlossen Schanghai (ots/PRNewswire) - WuXi Biologics ("WuXi Bio") (2269.HK), ein weltweit führender Anbiete.....

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Atryn [revo bioloigics, inc.]

These highlights do not include all the information needed to use ATryn safely and effectively. See full prescribing information for ATryn. ATryn, Antithrombin (Recombinant) Lyophilized powder for rec...

Anticoagulant citrate dextrose a [citra labs]

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3

Rejuvesol [citra labs llc]

rejuvesol red blood cell processing solution

PubMed Articles [110 Associated PubMed Articles listed on BioPortfolio]

Biosimilars in India; Current Status and Future Perspectives.

Many key biologics are scheduled to lose their patent by the year 2020, which will provide the opportunity to other biopharmaceutical companies to develop the similar biologics. Biosimilar or similar ...

Cutaneous lymphomas appearing under biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database.

Controversy exists regarding the risk and prognosis of lymphomas under biologics . Risk evaluation must consider the underlying medical condition -as chronic inflammatory diseases are associated with ...

Shifting paradigms revisited: biotechnology and the pharmaceutical sciences.

In 2003 Crommelin et al. published an article titled: 'Shifting paradigms: biopharmaceuticals versus low molecular weight drugs' (https://doi.org/10.1016/S0378-5173(03)00376-4). In the current comment...

The emergence of new biologics for severe asthma.

Patients with severe asthma experience severe symptoms and frequent exacerbations despite intensive treatment with inhaled and oral glucocorticoids. Biologics for severe asthma aim to reduce asthma-re...

Treatment of Psoriasis With Biologics and Apremilast in Patients With a History of Malignancy: A Retrospective Chart Review

Introduction: Biologics have transformed the management of moderate-to-severe psoriasis. The risk of developing a malignancy during treatment is an important consideration, and many studies have been ...

Clinical Trials [96 Associated Clinical Trials listed on BioPortfolio]

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

The purpose of this study is to compare the efficacy of Biologics + Methotrexate with Biologics + Tacrolimus measured by the disease activity score 28 (DAS28) erythrocyte sedimentation rat...

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Tofacitinib Registry of Patients With Ulcerative Colitis in Germany

This registry on Tofacitinib and biologics (anti-integrin/anti-TNF) in the treatment of ulcerative colitis (UC) patients in Germany will extend the prospective documentation of safety issu...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Companies [283 Associated Companies listed on BioPortfolio]

Batu Biologics

Founded in 2013, Batu Biologics is a preclinical biopharmaceutical company focusing on developing and commercializing allogeneic cell therapies in the area of immune modulation. T...

Batu Biologics Inc.

ABEC and WuXi Biologics

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover d...

Burst Biologics

Burst Biologics is a rapidly growing Biotechnology Company and federally registered tissue bank located in Boise, Idaho. Burst Biologics is a developer of effective tissue process...

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

More Information about "Batu Biologics Inc." on BioPortfolio

We have published hundreds of Batu Biologics Inc. news stories on BioPortfolio along with dozens of Batu Biologics Inc. Clinical Trials and PubMed Articles about Batu Biologics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Batu Biologics Inc. Companies in our database. You can also find out about relevant Batu Biologics Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record